Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis

• Raymund Dantes ,

  * E-mail: raydantes@gmail.com (RD) (RD); acattamanchi@medsfgh.ucsf.edu (AC) (AC)

  Affiliation Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• John Metcalfe,

  Affiliations Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Elizabeth Kim,

  Affiliation Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Midori Kato-Maeda,

  Affiliations Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Philip C. Hopewell,

  Affiliations Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Masae Kawamura,

  Affiliation Tuberculosis Control Section, Department of Public Health, San Francisco, California, United States of America

  ⨯
• Payam Nahid,

  Affiliations Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Adithya Cattamanchi

  * E-mail: raydantes@gmail.com (RD) (RD); acattamanchi@medsfgh.ucsf.edu (AC) (AC)

  Affiliations Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯